Genmab reports top line results in Phase III DLBCL trial

​Genmab has announced topline results from the Phase III EPCORE DLBCL-1 trial, highlighting improved PFS for its subcutaneous bispecific antibody, epcoritamab, in patients with R/R DLBCL.

The post Genmab reports top line results in Phase III DLBCL trial appeared first on Hospital Management.

 

Back to the Featured Stories
Genmab reports top line results in Phase III DLBCL trial

Featured Stories

Philips unveils new InkSpace Snuggle coil for paediatric imaging
Lyell doses first patient in Phase III trial for LBCL
Natus Sensory acquires medical technology company TheraB Medical
MSD receives FDA approval for Keytruda combo to treat ovarian cancer
Patient enrolment concludes in Senti Biosciences’ SENTI-202 Phase I trial

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us